Apoptosis inducing factor (AIF) is a novel apoptotic effector protein that induces chromatin condensation and large-scale (ϳ50 kbp) DNA fragmentation when added to purified nuclei in vitro. Confocal and electron microscopy reveal that, in normal cells, AIF is strictly confined to mitochondria and thus colocalizes with heat shock protein 60 (hsp60). On induction of apoptosis by staurosporin, c-Myc, etoposide, or ceramide, AIF (but not hsp60) translocates to the nucleus. This suggests that only the outer mitochondrial membrane (which retains AIF in the intermembrane space) but not the inner membrane (which retains hsp60 in the matrix) becomes protein permeable. The mitochondrio-nuclear redistribution of AIF is prevented by a Bcl-2 protein specifically targeted to mitochondrial membranes. The pan-caspase inhibitor Z-VAD.fmk does not prevent the staurosporin-induced translocation of AIF, although it does inhibit oligonucleosomal DNA fragmentation and arrests chromatin condensation at an early stage. ATP depletion is sufficient to cause AIF translocation to the nucleus, and this phenomenon is accelerated by the apoptosis inducer staurosporin. However, in conditions in which both glycolytic and respiratory ATP generation is inhibited, cells fail to manifest any sign of chromatin condensation and advanced DNA fragmentation, thus manifesting a 'necrotic' phenotype. Both in the presence of Z-VAD.fmk and in conditions of ATP depletion, AIF translocation correlates with the appearance of large-scale DNA fragmentation. Altogether, these data are compatible with the hypothesis that AIF is a caspase-independent mitochondrial death effector responsible for partial chromatinolysis.-Daugas, E., Susin, S. A., Zamzami, N., Ferri, K., Irinopoulou, T., Larochette, N., Prévost, M.-C., Leber, B., Andrews, D., Penninger, J., Kroemer, G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 14, 729 -739 (2000)
One of the decisive steps of the apoptotic cascade is the nonspecific permeabilization of the outer mitochondrial membrane culminating in the release of soluble intermembrane proteins from the mitochondrion (1-3). The exact mechanisms of membrane permeabilization are a matter of debate. Physical disruption of the outer mitochondrial membrane due to transient swelling of the matrix has been evoked by some authors (4, 5) . Others (6 -10) instead postulate the existence of nonspecific, proteinpermeable pores in the outer membrane. Irrespective of the exact mechanism of membrane permeabilization, it appears that antiapoptotic members of the Bcl-2 family (Bcl-2, Bcl-X L ) stabilize the mitochondrial membrane barrier function (1, 3, 4, 6, 7, 11) , whereas proapoptotic Bcl-2 homologues such as Bax or Bak tend to permeabilize mitochondrial membranes (8, 9, (12) (13) (14) . Both Bcl-2 and Bax have been shown to physically interact with proteins of the mitochondrial permeability transition (PT) pore complex (12, 14) , a finding that correlates with the close functional relationship between these structures (1, 3, 8, 11, 12, 14) .
Opening of the PT pore or translocation of Baxlike proteins from the cytosol to the mitochondrion cause the release of soluble intermembrane proteins from the mitochondrion, via the outer mitochondrial membrane (1-3, 6 -8, 12-14) . The first apoptogenic intermembrane protein to be molecularly identified has been cytochrome c. (2) . Cytochrome c can interact with the WD40 domains of the dATP/ ATP binding protein Apaf-1 in a reaction that finally leads to the autoactivation of pro-caspase-9 and initiation of the caspase activation cascade (15) . Many investigators have tacitly or overtly assumed that cytochrome c would be a major rate-limiting factor of apoptotic cell death (2, 4, 6, 7) . However, this notion does not withstand experimental verification because 1) in most if not all models of stress-induced mammalian apoptosis, inhibition of caspases does not prevent cell death (16 -20) and 2) mitochondria release factors other than cytochrome c participate in the apoptotic process. This applies in particular to 'apoptosis inducing factor' (AIF), a mitochondrial intermembrane protein that has the unique property to induce apoptosis-like changes in purified nuclei in vitro in a caspase-independent fashion (1, 3) .
AIF has recently been characterized at the molecular level and discovered to be a novel mitochondrial intermembrane flavoprotein with significant homology to bacterial and plant oxidoreductases (21) . This protein is synthesized as a nonapoptogenic precursor in the cytoplasm and efficiently imported into the mitochondrial intermembrane space. Import through the general impart pathway culminates into the proteolytic removal of the amino-terminal mitochondrial targeting sequence, attachment of a flavin adenine dinucletide group, and refolding of the protein, which becomes potentially apoptogenic (21) . On induction of apoptosis, AIF redistributes to the nucleus. Moreover, when added to purified nuclei, AIF induces partial chromatin condensation as well as large-scale (ϳ50 kbp) DNA fragmentation in a caspase-independent fashion. These nuclear changes resemble to some extent those observed in intact cells in which apoptosis is induced in conditions of caspase inhibition (16 -19) , suggesting that AIF may be responsible for at least some of the caspase-independent features of apoptosis.
Recent data indicate that the paradigmatic opposition between apoptosis and necrosis is less clear than this has been generally thought. Thus, necrosis can be prevented in some cases by Bcl-2 (22) and may involve an early mitochondrial permeabilization event (22) (23) (24) (25) . Moreover, classical protocols of apoptosis induction give rise to a more necrotic phenotype when cytosolic ATP levels are low (26, 27) . These finding have been interpreted to mean that the early phase of apoptosis and of some types of necrosis may involve common mitochondrial events. Only at the postmitochondrial level, depending on the ATP concentration and caspase activation, would the 'decision' between apoptotic and necrotic cell death be made (24, 26, 27) .
Intrigued by these possibilities, we have used confocal immunofluorescence microscopy as well as immune electron microscopy to determine the subcellular localization of AIF in a variety of different apoptosis-inducing conditions, in cells that overexpress Bcl-2, as well as in conditions in which caspase activation is prevented or ATP levels are low. As shown here, AIF translocation can occur in experimental conditions in which advanced apoptosis is prevented by caspase inhibition. Moreover, AIF translocation can occur in conditions of ATP depletion that lead to nonapoptotic cytolysis (necrosis).
MATERIALS AND METHODS

Cell lines and apoptosis induction
Rat-1 cells transfected with a control vector (CMV), with a human Bcl-2/Act A fusion protein specifically targeted to mitochondria (28) , and/or a estrogen receptor/c-myc fusion protein (29) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with L-glutamine, antibiotics, 2 mM pyruvate, and 10% fetal calf serum (FCS). Cells were cultured in the presence of staurosporine ( 
Immunostaining protocols
A rabbit antiserum was generated against a mixture of three peptides derived from the mouse AIF aa sequence (aa 151-170, 166 -185, 181-200, coupled to keyhole limpet hemocyanine, generated by Syntem, Nîmes, France). This antiserum (ELISA titer ϳ10.000) was used (diluted 1/1000) on paraformaldehyde (4% w:v) and picric acid-fixed (0.19% v:v) cells (cultured on 100 m coverslips; 18 mm Ø; Superior, Germany), and revealed with a goat anti-rabbit IgG conjugated to phycoerythrine (PE) (Southern Biotechnology, Birmingham, Ala.). Control experiments performed with the pre-immune antiserum or in the presence of an excess (100 M) of the three immunogenic peptides confirmed that all detectable fluorescence was specific (not shown). Cells were counterstained for the detection of cytochrome c (mAb 6H2.B4 from Pharmingen, revealed by a goat anti-mouse IgG fluorescein isothiocyanate (FITC) conjugate; Southern Biotechnology), hsp60 (mAb H4149 from Sigma, revealed by the same antimouse IgG FITC conjugate), or DNA (Sytox Green from Molecular Probes, 25 nM, 15 min of incubation at room temperature).
for FITC and PE, as well as a Leica camera. CMXRos and Sytox Green fluorescence were monitored using the PE and FITC filters, respectively. Confocal microscopy was performed on a Leica TC-SP (Leica Microsystems, Heidelberg, Germany) equipped with an ArKr laser mounted on an inverted Leica DM IFBE microscope with an 63 ϫ 1,32 NA oil objective. To avoid cross talk between different fluorochromes, images were acquired in a sequential fashion. For immunoelectron microscopy, cells were fixed for 1 h at 4°C with 4% paraformaldehyde in 0.1 M phosphatebuffered saline (PBS), pH 7.4, washed three times in PBS, and embedded in 10% gelatin at 37°C, then in 1.7 M sucrose ϩ PVP15% overnight. Ultrathin sections (60 nm) were floated on drops of anti-AIF antiserum (1/100 dilution in PBS ϩ 1% bovine serum albumin ϩ 1% gelatin, pH 7.4), then revealed by an immunogold (10 nm) anti-rabbit Ig conjugate, Amersham, Arlington Heights, Ill.), counterstained with uralylacetate-oxalate, and embedded in methylcellulose, following standard protocols (31) . Cells that demonstrate a clear AIF staining of the nucleus were scored as positive for AIF translocation. Cells having lost the mitochondrial staining pattern for cytochrome c or CMXRos in favor of a diffuse cyosolic staining were scored positive for cytochrome translocation or as ⌬⌿ m low , respectively. Using these criteria, the frequency of 'intermediate' cases (cytochrome c release or loss of CMXRos staining only in a part of the cell was low (Ͻ2%). Such intermediate cases were scored as negative events. A minimum of 200 cells were monitored for these parameters for each data point.
DNA gel electrophoresis
For the detection of oligonucleosomal DNA fragmentation, nuclear DNA from lysed cells (treated with protease K and RNase according to standard protocols) was subjected to conventional horizontal agarose gel electrophoresis (1%) followed by ethidium bromide staining (32, 33) . For pulse field gel electrophoresis (PAGE), DNA was prepared from agarose plugs (1ϫ10 6 cells) (34) digested twice with proteinase K (1 mg/ml; 50°C; 12 h) in NDS buffer (0.5 M EDTA, 10 mg/ml lauroyl sarcosine), washed in TBE ϫ 0.5, followed by electrophoresis in a Bio-RadCHEF-DR II (Richmond, Calif.) equipment (1% agarose; TBE ϫ 0.5; 200 V; 24 h; pulse wave 60 s; 120°angle). Molecular weight standards were from Bio-Rad (Yeast chromosomes) and Appligene (Raoul; Illkirch, France). 
RESULTS AND DISCUSSION
Confocal and electron microscopic evidence for the mitochondrio-nuclear translocation of AIF
Immunofluorescence detection of AIF using a PE conjugate (red fluorescence) normally yields a punctuate cytoplasmic staining pattern with some preference for the perinuclear area. This staining profile is typical for a mitochondrial localization. Accordingly, double-staining experiments allowing for the simultaneous detection of a soluble mitochondrial matrix protein, hsp60 (revealed by an FITC conjugate; green fluorescence), indicate a strict coincidence between AIF and hsp60 (yellow fluorescence resulting from the overlap of green and red light) (Fig. 1A) . When treated with the tyrosine kinase inhibitor STS, Rat-1 cells rapidly undergo apoptosis. This process is accompanied by the mitochondrial release of AIF, as indicated by two observations. First, in double-staining experiments (AIF vs. hsp60), areas of purely red fluorescence indicating the sole presence of AIF, presumably in an extramitochondrial localization, can be detected (Fig. 1B) both by visual inspection and by computerized image analysis (right panel in Fig. 1B ). These data underline the differential permeabilization of the outer mitochondrial membrane (which causes AIF escape) and the inner mitochondrial membrane (which retains hsp60), at least for the proteins investigated. Immunodetection of the matrix protein superoxide dismutase 2 (SOD2, 30 kDa) confirmed the matrix retention of yet another factor (not shown).
In normal untreated cells, AIF (revealed by PE in red) spares the nucleus (stained by Sytox-green, a DNA intercalating dye) (Fig. 2A) . However, after induction of apoptosis, a large portion of AIF is found within the nucleus, as determined by confocal analyses (Fig. 2B) . This interpretation was confirmed by immunoelectron microscopy, showing that before induction of apoptosis mitochondria stain for AIF (Fig. 3A) , yet lose most of the specific signal after STS treatment (not shown). Nuclei from control cells lack AIF (Fig. 3B) . In contrast, in nuclei from STS-treated cells, immunogold particles reveal the presence of AIF (Fig.  3C ) . Collectively, these data confirm that after induction of apoptosis, AIF redistributes from mitochondria to the nucleus. 
Temporal relationship between AIF and
cytochrome c release Staurosporin is known to induce the release of cytochrome c from mitochondria to the cytosol (2, 35). Since the redistribution of cytochrome c has been reported to be an early event of the apoptotic process (2, 35), we determined the temporal and spatial relationship between cytochrome c and AIF release. As revealed by two-color immunofluorescence detection of cytochrome c and AIF, both proteins normally colocalize in mitochondria (Fig.
4A
. After 4 h of STS treatment (2 M), most cells (Ͼ80%) manifest a phenotype where the mitochondrial pattern of cytochrome c distribution is lost and cytochrome c relocalizes to the cytosol; AIF partially redistributes to the nucleus, giving rise to a spatial separation of the two mitochondrial intermembrane proteins. This same phenotype is found in about half of the cells 3 h after initiation of the treatment (example 2 in Fig. 4B ). Moreover, in a significant portion of cells (36%), which probably represent a short transitional step of the apoptotic cascade, AIF-specific fluorescence (red) is translocated to the nucleus, whereas mitochondria still brightly stain for cytochrome c (green, example 1 in Fig. 4B ). The percentage of cells having translocated AIF but not cytochrome drops to Ͻ2% when the incubation with STS is prolonged to 8 h. Within the limits of detection by quantitative confocal immunofluorescence, these data suggest that AIF is released shortly before cytochrome c.
Temporal relationship between mitochondrial change and nuclear chromatin condensation
Chromatin condensation, as monitored by staining with the intercalating dye Hoechst 33342 or Sytox-green, advances gradually during the apoptotic process. Several stages of nuclear apoptosis can be distinguished: stage I with rippled nuclear contours and a rather partial chromatin condensation; stage IIa with marked peripheral chromatin condensation; and stage IIb with formation of nuclear bodies (Fig. 5A) . Kinetic studies reveal that these stages actually reflect successive step in the apoptotic process (Fig. 5B) . We have correlated the translocation of cytochrome c and AIF with the advancement of nuclear apoptosis. It appears that AIF is translocated in nearly all cells in which morphological changes in the nucleus have become apparent, including stage I of the process. In contrast, cytochrome c translocation is only found in approximately half of cells in stage 1 of the process and is only complete (Ͼ90%) at stage IIa (Fig. 5C ). These data are compatible with the two-color immunofluorescence determinations, suggesting that AIF release precedes full cytochrome c release ( Fig. 4 ; see above). Whenever nuclear apoptosis becomes apparent (including stage I), the ⌬⌿ m is reduced in most cells, as indicated by staining with the potential-sensitive dye CMXRos (Fig. 5A, C ) . However, a significant fraction of cells with nuclear apoptosis (between 10 and 20%) retained a mitochondrial staining pattern of CMXRos, suggesting that at least a few mitochondria can maintain the ⌬⌿ m during apoptosis, as previously suggested (35) .
Regulation of AIF translocation by multiple effectors: Bcl-2, c-Myc, DNA damage, and ceramide
Overexpression of Bcl-2 has been suggested to inhibit apoptosis mainly by preventing the release of cytochrome c (6, 7). Using a Bcl-2/ActA fusion protein specifically targeted to the mitochondrion (28), we have confirmed that Bcl-2 prevents the release of cytochrome c in response to STS (not shown). Mitochondrion-targeted Bcl-2 also prevents the release of AIF. Thus, in conditions in which vector-only transfected cells readily undergo a mitochondrio-nuclear translocation of AIF in response to STS (Fig. 1B, Fig. 2B ), Rat-1 cells overexpressing Bcl-2 withhold AIF in their mitochondria (Fig. 1C,  Fig. 2C ). Release of AIF is not restricted to apoptosis induction by STS-mediated tyrosine kinase inhibition. Rather, we have observed that multiple different death triggers can provoke the relocalization of AIF. This applies to apoptosis triggered by serum withdrawal and simultaneous activation of an estrogen receptor c-Myc fusion protein, which translocates to the nucleus after addition of estradiol (Fig.  6A) . Moreover, several additional apoptosis inducers including the topoisomerase II inhibitor etoposide (Fig. 6B ) and the proapoptotic second messenger ceramide (Fig. 6C) , as well as adriamycin and cisplatin (not shown), induce the mitochondrio-nuclear translocation of AIF, suggesting that the redistribution of AIF is a general feature of the apoptotic process.
AIF translocation is a caspase-independent phenomenon
Inhibition of caspases using Z-VAD.fmk does not prevent cell death induced by several proapoptotic stimuli including STS (19) . However, Z-VAD.fmk prevents or retards advanced nuclear apoptosis. Four hours after addition of STS, the preponderant phenotype is stage I (56Ϯ5%), whereas 6 h later most cells are in stage IIaϩb (72Ϯ3%). In the presence of Z-VAD.fmk, cells mostly remain in stage I (Fig. 7E) . Concomitantly, Z-VAD.fmk prevents the oligonucleosomal DNA fragmentation induced by STS (Fig.  7D ). These internal controls indicate that Z-VAD-.fmk did prevent caspase-dependent features of apoptosis. However, Z-VAD.fmk did not prevent the translocation of AIF to the nucleus (Fig. 7A, B) or loss of the mitochondrial transmembrane potential (Fig. 7C) . Moreover, Z-VAD.fmk failed to prevent large-scale DNA fragmentation to fragments of ϳ 50 kbp, as determined by pulse field gel electrophoresis (Fig. 7D) . As a result, it appears that the mitochondrio-nuclear translocation of AIF and concomitant ϳ 50 kbp DNA fragmentation is caspase-independent.
AIF translocation is ATP-independent
One strategy of preventing the acquisition of apoptotic morphology consists in the depletion of ATP (27) . It is generally assumed that ATP depletion results in the functional inactivation of the ATP binding caspase activator Apaf-1, thereby preventing caspase activation (15, 27) . ATP depletion is of pathophysiological interest because it mimics situations of ischemia in which cells die from necrosis. As Figure 6 . AIF translocation in various models of apoptosis. A) AIF translocation induced by c-myc and serum withdrawal. Rat cells transfected with an estrogen receptor/cmyc fusion protein (29) were left untreated or exposed to ␤-estradiol plus low serum concentration to induce apoptosis, followed by double staining for AIF ϩ hsp60 or AIF ϩ DNA (as in Fig.  1 and 2) . Culture of cells with ␤-estradiol in the presence of 10% serum or culture in 1% serum in the absence of ␤-estradiol did not induce apoptosis and failed to provoke the translocation of AIF (not shown). B) AIF translocation induced by etoposide. C) AIF translocation induced by ceramide. Representative apoptotic cells are shown.
shown in Fig. 8 , cells kept in a glucose-free, oligomycin A-supplemented medium (which abolishes both glycolytic ATP and respiratory ATP generation; ref 27) die within 6 to 8 h. The aspect of nuclei obtained in these conditions is clearly nonapoptotic, different from all stages of apoptotic nuclear chromatin redistribution described above. Cells manifest a homogeneous chromatin condensation (note that the scale in Fig. 8A -C differs from that in Figs. 1, 2 and 4 -7) , which we judged to be necrotic (27) . At this point, AIF accumulates in the nucleus (Fig. 8A, B) . Addition of STS to ATP-depleted cells accelerates cellular demise (Fig. 8E) , and again cells with chromatin condensation demonstrate mitochondrio-nuclear AIF translocation (Fig. 8A, B) . Thus, the translocation of AIF does not depend on ATP, similar to what has been reported for the translocation of cytochrome c (ref 36 ) and data not shown). In the context of ATP depletion, cells treated with STS only manifest a reduction in nuclear size, without any detectable changes in chromatin distribution (Fig.  8B, C) . ATP depletion does prevent STS-induced oligonucleosomal DNA fragmentation, yet has no effect on ϳ50 kbp DNA fragmentation (Fig. 8D) . Mitochondrion-targeted Bcl-2 prevents the necrotic cell death induced by ATP depletion (Fig. 8E) .
CONCLUDING REMARKS
As shown in this study, mitochondrio-nuclear translocation of AIF appears to be a constant feature of cell death, independent of the death inducing conditions (protein kinase inhibition, c-Myc overexpression, ceramide, in vitro chemotherapy, ATP depletion; Figs. 1-6 ) and independent of the death modality (apoptosis or primary necrosis; Figs. 7, 8) . Thus, redistribution of AIF to the nucleus, which strongly correlates with large-scale DNA fragmentation, was found to be caspase independent (Fig. 7) and ATP independent (Fig. 8) . Mitochondria release AIF relatively early, before they completely release cytochrome c (Figs. 4, 5 ). Kinetic analyses (Fig. 5) suggest that AIF translocation to the nucleus coincides with initial chromatin condensation (wrinkled pattern of peripheral condensation, stage I), whereas cytochrome c release correlates with a more advanced pattern of chromatin condensation (stage II). The differential release kinetics of AIF and cytochrome c might be explained by the preferential localization of cytochrome c to the inner mitochondrial membrane, mainly via weak electrostatic interactions (37, 38) , which would retard its release.
When added to purified nuclei in a cell-free system, recombinant AIF has two major effects. It causes peripheral chromatin condensation and large-scale DNA fragmentation, yet fails to generate nuclear bodies or oligonucleosomal DNA fragments (21) . These latter changes have been attributed to the caspase-dependent activation of caspase-activated DNase (CAD), also called DNA fragmentation factor (DFF40) (39 -42) . In conditions in which caspases are inhibited, yet mitochondrial factors such as AIF and cytochrome c are released, cells manifest only partial chromatin condensation (stage I) and largescale DNA fragmentation (Fig. 7) . These results are in complete agreement with those obtained in the cell-free system, as well as with the staging of apoptosis (Fig. 5) induced in the absence of caspase inhibitors. They suggest that AIF is indeed the caspaseindependent factor responsible for initial chromatin condensation (stage I) and large-scale DNA fragmentation (Fig. 9) . In contrast, the data obtained in conditions of ATP depletion are more difficult to be accommodated in this scheme. In intact cells, shortage of ATP abolishes all signs of inhomogeneous (apoptotic) chromatin condensation yet does not affect translocation of AIF into the nucleus or prevent large-scale DNA fragmentation (Fig. 8) . However, in the cell free system, ATP is dispensable for AIF-induced chromatin condensation (21) . So far we have no explanation for this apparent paradox. In any case, the data obtained in intact cells are incompatible with the simple assumption that ATP depletion affects the phenotypic manifestations of cell death solely by preventing caspase activation. Rather, additional effects of ATP shortage must be postulated.
Irrespective of these details, the data presented in this study suggest an overall scheme of cell death regulation in which Bcl-2-inhibitible mitochondrial alterations are rate-limiting for both apoptosis and necrosis. Increase in mitochondrial membrane permeability results in the release of apoptogenic factors, including AIF and cytochrome c. AIF then accounts for initial apoptotic changes in the nucleus, whereas cytochrome c triggers caspase activationand CAD-dependent downstream events leading to advanced nuclear apoptosis (Fig. 9) . At present, it is not clear whether AIF truly participates in the regulation of cell death (e.g., by determining thresholds of death induction) or whether its contribution is limited to the post mortem manifestations of cell death, beyond the Bcl-2-regulated checkpoint. Since some AIF distributes to the cytosol and since AIF may affect mitochondrial function, both hypotheses appear plausible (3) . Genetic studies involving homologous recombination of the AIF gene will resolve this issue in the future. Irrespective of these considerations, it appears that the translocation of AIF from a mitochondrial to an extramitochondrial localization occurs both in apoptosis and necrosis and thus may participate in the common death pathway. Figure 9 . Hypothetical sequence of postmitochondrial events leading to nuclear apoptosis. Various apoptosis inducers act on mitochondria to permeabilize the outer mitochondrial membrane and to release AIF and cytochrome c. AIF directly translocates to the nucleus where it provokes (ATP-independent) large-scale DNA fragmentation and (ATP dependent) initial chromatin condensation. Cytochrome c activates caspases, which deinhibit caspase-activated DNAse (CAD), the factor responsible for advanced chromatin condensation and oligonucleosomal DNA fragmentation.
